Search Results for "Using Dextromethorphan Kidney"
Original Source: Dextromethorphan and Silymarin in Chronic Kidney Disease (CKD) Patients
The investigators test the renal and cardiovascular protective effects dextromethorphan and silymarin on patients with the proteinuric chronic kidney diseases, who enrolled in our clinical trial, had progressing kidney diseases and merit aggressive anti-inflammatory therapy.
Matching Channels
Matching News
FDA approves Tris Dextromethorphan Polistirex extended-release oral suspension
Perrigo Company has announced FDA approval of Tris Pharma's abbreviated new drug application (ANDA) for Dextromethorphan Polistirex extended-release oral suspension.
MONMOUTH JUNCTION, N.J., May 31, 2012 /- Tris Pharma, a technology driven specialty pharmaceutical company, announced today that the US Food and Drug Administration (FDA) has approved the first-e...
Kidney Stones May Be Tied to Later Kidney Problems
FRIDAY, Aug. 31 (HealthDay News) -- New research suggests that people who have kidney stones -- especially younger women -- are slightly more likely to develop more serious kidney problems later in li...
Tolvaptan improves kidney health in polycystic kidney disease
A vasopressin V2-receptor blocker slows the increase in total kidney volume and decline in kidney function in patients with autosomal dominant polycystic kidney disease, report US researchers.
March Is National Kidney Month. What You Need To Know To Keep Your Kidney's Healthy
With more than 20 million or one in 10 American adults having some level of chronic kidney disease, the need for proper kidney health education is crucial.�According to Dr. Kozin, "Early kidney di...
Nuedexta dextromethorphan/quinidine neurology data
Nuedexta dextromethorphan/quinidine regulatory update
NIH highlights lifelong impact of acute kidney injury
In observance of World Kidney Day on March 14, the National Institutes of Health is raising awareness of the long term effects of acute kidney injury (AKI) -- a sudden loss of kidney function. Researc...
Matching PubMed Articles
Dextromethorphan inhibition of voltage-gated proton currents in BV2 microglial cells.
Dextromethorphan, an antitussive drug, has a neuroprotective property as evidenced by its inhibition of microglial production of pro-inflammatory cytokines and reactive oxygen species. The microglial...
Developmental toxicity of dextromethorphan in zebrafish embryos/larvae.
Dextromethorphan is widely used in over-the-counter cough and cold medications. Its efficacy and safety for infants and young children remains to be clarified. The present study was designed to use ze...
PURPOSE: Dextrorphan, a major metabolite of dextromethorphan, produces the duration of spinal and cutaneous anesthesia similar to bupivacaine. The purpose of this study was to test the central nervous...
Effect of dextromethorphan on human K(v)1.3 channel activity: involvement of C-type inactivation.
Dextromethorphan exhibits neuroprotective effects against inflammation-mediated neurodegeneration. However, relatively little is known regarding the molecular mechanism for this inflammation-mediated...
We use the combination of liquid chromatography/quadrupole-time-of-flight mass spectrometry (LC/Q-TOF-MS) and urine metabolic profiling to find and identify the metabolites of dextromethorphan, a comm...
